Company · founded 2008
Inhibikase Therapeutics (United States)
Atlanta, United States · inhibikase.com
- Citations, last 5 years
- 47
- Works, last 5 years
- 5
- h-index
- 8
- Scientists listed
- 0
- Grants since 2016
- 10
Grants received
2021–2023 · research · R43
Kinase activation in multiple system atrophy
Milton H. Werner · Inhibikase Therapeutics (United States) · funded by National Institutes of Health
2017–2019 · research · R44
Advanced therapeutic for Parkinson's Disease
Milton H. Werner · Inhibikase Therapeutics (United States) · funded by National Institutes of Health
2017–2022 · research · R44
Advanced therapeutic for Parkinson's Disease
Milton H. Werner · Inhibikase Therapeutics (United States) · funded by National Institutes of Health
2017–2019 · research · R44
Advanced therapeutic for Parkinson's Disease
Milton H. Werner · Inhibikase Therapeutics (United States) · funded by National Institutes of Health
2017–2019 · research · R44
Advanced PML antiviral
Milton H. Werner · Inhibikase Therapeutics (United States) · funded by National Institutes of Health
2017–2018 · research · R43
Prodrug treatment for CML
Milton H. Werner · Inhibikase Therapeutics (United States) · funded by National Institutes of Health
2017–2020 · research · R44
Advanced PML antiviral
Milton H. Werner · Inhibikase Therapeutics (United States) · funded by National Institutes of Health
2017–2021 · research · R44
Advanced Prodrug Treatment for CML
Milton H. Werner · Inhibikase Therapeutics (United States) · funded by National Institutes of Health
2017–2021 · research · R44
Advanced therapeutic for Parkinson's Disease
Milton H. Werner · Inhibikase Therapeutics (United States) · funded by National Institutes of Health
2017–2020 · research · R44
Advanced Prodrug Treatment for CML
Milton H. Werner · Inhibikase Therapeutics (United States) · funded by National Institutes of Health
